U.S. Neurology Associates
PrivateLast Round
Growth Equity
Jan 9, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
U.S. Neurology Associates is a healthcare services company that provides administrative, operational, and strategic support to community-based neurology practices to enhance patient care and practice growth.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Vertical SaaS, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
U.S. Neurology Associates Comparables
Compare U.S. Neurology Associates with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autonomy Health | 88% | |
| PracticeCore | 76% | |
| United Musculoskeletal Partners | 68% |
U.S. Neurology Associates Funding Rounds
Historical fundraising activity
U.S. Neurology Associates Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M33 Growth | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Raised Growth Equity round led by M33 Growth.
U.S. Neurology Associates Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about U.S. Neurology Associates's valuation, stock price, and market status.
Is U.S. Neurology Associates a public or private company?
U.S. Neurology Associates is a private company.
What is the current stock price of U.S. Neurology Associates?
U.S. Neurology Associates is a private company, so its shares have no public market price. Caplight tracks U.S. Neurology Associates's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is U.S. Neurology Associates worth (valuation)?
Valuation information for U.S. Neurology Associates is not publicly available.
Can I buy U.S. Neurology Associates stock?
U.S. Neurology Associates shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was U.S. Neurology Associates's last funding round?
U.S. Neurology Associates's most recent funding round was Growth Equity on January 9, 2026.
Who are the main investors in U.S. Neurology Associates?
Key investors in U.S. Neurology Associates include M33 Growth.
Will U.S. Neurology Associates IPO soon?
No public IPO plans have been announced for U.S. Neurology Associates.
How can I track U.S. Neurology Associates secondary market activity?
Caplight tracks bids, offers, and trades in U.S. Neurology Associates's shares on secondary markets.